These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 31462215

  • 1. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
    Kim EJ, Kim YC, Ahn JY, Jeong SJ, Ku NS, Choi JY, Yeom JS, Song YG.
    BMC Infect Dis; 2019 Aug 28; 19(1):754. PubMed ID: 31462215
    [Abstract] [Full Text] [Related]

  • 2. Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy.
    Kim SH, Cho SY, Kang CI, Seok H, Huh K, Ha YE, Chung DR, Lee NY, Peck KR, Song JH.
    Ann Hematol; 2018 Feb 28; 97(2):343-350. PubMed ID: 29138886
    [Abstract] [Full Text] [Related]

  • 3. Comparisons between patients with trimethoprim-sulfamethoxazole-susceptible and trimethoprim-sulfamethoxazole-resistant Stenotrophomonas maltophilia monomicrobial bacteremia: A 10-year retrospective study.
    Wang CH, Lin JC, Lin HA, Chang FY, Wang NC, Chiu SK, Lin TY, Yang YS, Kan LP, Yang CH, Chan MC, Yeh KM.
    J Microbiol Immunol Infect; 2016 Jun 28; 49(3):378-86. PubMed ID: 25081988
    [Abstract] [Full Text] [Related]

  • 4. Clinical characteristics and prognostic factors of patients with Stenotrophomonas maltophilia bacteremia.
    Lai CH, Chi CY, Chen HP, Chen TL, Lai CJ, Fung CP, Yu KW, Wong WW, Liu CY.
    J Microbiol Immunol Infect; 2004 Dec 28; 37(6):350-8. PubMed ID: 15599467
    [Abstract] [Full Text] [Related]

  • 5. Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia.
    Imoto W, Yamada K, Yamairi K, Shibata W, Namikawa H, Yukawa S, Yoshii N, Nakaie K, Hirose A, Koh H, Watanabe T, Asai K, Nakamae H, Kaneko Y, Kawaguchi T, Hino M, Kakeya H.
    Intern Med; 2020 Dec 28; 59(2):193-198. PubMed ID: 31941869
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia.
    Jeon YD, Jeong WY, Kim MH, Jung IY, Ahn MY, Ann HW, Ahn JY, Han SH, Choi JY, Song YG, Kim JM, Ku NS.
    Medicine (Baltimore); 2016 Aug 28; 95(31):e4375. PubMed ID: 27495046
    [Abstract] [Full Text] [Related]

  • 7. The clinical impact of Stenotrophomonas maltophilia bacteremia on the 30-day mortality rate in patients with hematologic disorders: a single-institution experience.
    Bao H, Qiao Y, Liu D, Chen J, Wu X, Hu X, Ma X, Wu D.
    Infection; 2020 Apr 28; 48(2):205-212. PubMed ID: 31686323
    [Abstract] [Full Text] [Related]

  • 8. Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center.
    Huang YC, Wu PF, Lin YT, Wang FD.
    J Microbiol Immunol Infect; 2019 Apr 28; 52(2):304-311. PubMed ID: 30097388
    [Abstract] [Full Text] [Related]

  • 9. Stenotrophomonas maltophilia bacteremia in adults: four years' experience in a medical center in northern Taiwan.
    Wang WS, Liu CP, Lee CM, Huang FY.
    J Microbiol Immunol Infect; 2004 Dec 28; 37(6):359-65. PubMed ID: 15599468
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pathogenic significance of hemorrhagic pneumonia in hematologic malignancy patients with Stenotrophomonas maltophilia bacteremia: clinical and microbiological analysis.
    Kim SH, Cha MK, Kang CI, Ko JH, Huh K, Cho SY, Chung DR, Peck KR.
    Eur J Clin Microbiol Infect Dis; 2019 Feb 28; 38(2):285-295. PubMed ID: 30421302
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.
    Cho SY, Lee DG, Choi SM, Park C, Chun HS, Park YJ, Choi JK, Lee HJ, Park SH, Choi JH, Yoo JH.
    BMC Infect Dis; 2015 Feb 18; 15():69. PubMed ID: 25887489
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for death from Stenotrophomonas maltophilia bacteremia.
    Osawa K, Shigemura K, Kitagawa K, Tokimatsu I, Fujisawa M.
    J Infect Chemother; 2018 Aug 18; 24(8):632-636. PubMed ID: 29673561
    [Abstract] [Full Text] [Related]

  • 15. Bacteraemia due to Stenotrophomonas maltophilia: an analysis of 45 episodes.
    Friedman ND, Korman TM, Fairley CK, Franklin JC, Spelman DW.
    J Infect; 2002 Jul 18; 45(1):47-53. PubMed ID: 12217732
    [Abstract] [Full Text] [Related]

  • 16. Stenotrophomonas maltophilia bacteremia and pneumonia at a tertiary-care oncology center: a review of 16 years.
    Velázquez-Acosta C, Zarco-Márquez S, Jiménez-Andrade MC, Volkow-Fernández P, Cornejo-Juárez P.
    Support Care Cancer; 2018 Jun 18; 26(6):1953-1960. PubMed ID: 29307014
    [Abstract] [Full Text] [Related]

  • 17. [Risk factors and clinical charasteristics of Stenotrophomonas maltophilia bacteremia: a comparison with bacteremia due to other glucose-non fermenters].
    Hotta G, Matsumura Y, Kato K, Nakano S, Yunoki T, Yamamoto M, Nagao M, Ito Y, Takakura S, Ichiyama S.
    Kansenshogaku Zasshi; 2013 Sep 18; 87(5):596-602. PubMed ID: 24195169
    [Abstract] [Full Text] [Related]

  • 18. Clinical Features and Risk Factors for Development of Breakthrough Gram-Negative Bacteremia during Carbapenem Therapy.
    Lee JY, Kang CI, Ko JH, Lee WJ, Seok HR, Park GE, Cho SY, Ha YE, Chung DR, Lee NY, Peck KR, Song JH.
    Antimicrob Agents Chemother; 2016 Nov 18; 60(11):6673-6678. PubMed ID: 27572416
    [Abstract] [Full Text] [Related]

  • 19. Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate.
    Alsuhaibani M, Aljarbou A, Althawadi S, Alsweed A, Al-Hajjar S.
    Antimicrob Resist Infect Control; 2021 Jan 22; 10(1):19. PubMed ID: 33482916
    [Abstract] [Full Text] [Related]

  • 20. Fatal hemorrhagic pneumonia in patients with hematologic diseases and Stenotrophomonas maltophilia bacteremia: a retrospective study.
    Zhu L, Wang L, Zhang Y, Chen R, Li X, Sun J, Zhou D, Zhu M, Zheng X, Li L, Zhu J, Xie M, Yang X, Yu W, Tong H, Zhu H, Xie W, Jin J, Ye X.
    BMC Infect Dis; 2021 Jul 31; 21(1):723. PubMed ID: 34332526
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.